Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy

Trial Profile

Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2019

At a glance

  • Drugs Dexrazoxane (Primary) ; Doxorubicin
  • Indications Chemotherapy-induced damage
  • Focus Therapeutic Use
  • Acronyms HEART
  • Most Recent Events

    • 07 Aug 2018 Planned primary completion date changed from 1 Jan 2019 to 30 Mar 2022.
    • 05 Apr 2016 Trial protocol (Treatment arms, study design, endpoints) amended as reported by ClinicalTrials.gov record.
    • 22 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top